The specificity of prescription patterns in secondary stroke prevention

Por Bellelli, G, Trabucchi, M, Landi, F, Onder, G, Bernabei, R
Publicado em 2004

Multimorbidity: Epidemiology and Models of Care

Por Marengoni, A., Melis, R. J. F., Prados Torres, A., Onder, G.
Publicado no Biomed Res Int (2016)

Antithrombotic drugs in secondary stroke prevention among a community dwelling older population

Por Landi, F, Cesari, M, Onder, G, Zamboni, V, Lattanzio, F, Russo, A, Barillaro, C, Bernabei, R
Publicado em 2003

Cognitive dysfunction as a major determinant of disability in patients with heart failure: results from a multicentre survey

Por Zuccala, G, Onder, G, Pedone, C, Cocchi, A, Carosella, L, Cattel, C, Carbonin, P, Bernabei, R
Publicado em 2001

Lifetime occupation and physical function: a prospective cohort study on persons aged 80 years and older living in a community

Por Russo, A, Onder, G, Cesari, M, Zamboni, V, Barillaro, C, Capoluongo, E, Pahor, M, Bernabei, R, Landi, F
Publicado em 2006

Development and Validation of a Risk Model for Predicting Adverse Drug Reactions in Older People during Hospital Stay: Brighton Adverse Drug Reactions Risk (BADRI) Model

Por Tangiisuran, Balamurugan, Scutt, Greg, Stevenson, Jennifer, Wright, Juliet, Onder, G., Petrovic, M., van der Cammen, T. J., Rajkumar, Chakravarthi, Davies, Graham
Publicado em 2014

CARLA TASK FORCE ON SARCOPENIA: PROPOSITIONS FOR CLINICAL TRIALS

Por VAN KAN, G. ABELLAN, ANDRÉ, E., BISCHOFF-FERRARI, H.A., BOIRIE, Y., ONDER, G., PAHOR, M., RITZ, P., ROLLAND, Y., SAMPAIO, C., STUDENSKI, S., VISSER, M., VELLAS, B.
Publicado no J Nutr Health Aging (2009)

SARCOPENIA: ITS ASSESSMENT, ETIOLOGY, PATHOGENESIS, CONSEQUENCES AND FUTURE PERSPECTIVES

Por ROLLAND, Y., CZERWINSKI, S., VAN KAN, G. ABELLAN, MORLEY, J.E., CESARI, M., ONDER, G., WOO, J., BAUMGARTNER, R., PILLARD, F., BOIRIE, Y., CHUMLEA, W.M.C., VELLAS, B.
Publicado em 2008